News | Sudden Cardiac Arrest | May 16, 2018

Exposure to Air Pollution on Cold Days Can Trigger Sudden Cardiac Death in Women

New study finds all sudden cardiac death cases in over 110,000 women took place at air pollution levels below EPA quality standards

Sudden cardiac arrest - Exposure to Air Pollution on Cold Days Can Trigger Sudden Cardiac Death in Women. #HRS2018

May 16, 2018 — A new study shows that women exposed to particular matter (PM) and lower temperatures for even a short amount of time are at an increased risk of sudden cardiac death (SCD). PM is a mixture of hazardous, small particle pollutants that includes dust, pollen, soot, smoke and liquid droplets that get into the air. The study is the largest of its kind in the United States to date and was presented at Heart Rhythm 2018, the Heart Rhythm Society's 39th Annual Scientific Sessions. 

Sudden cardiac arrest (SCA) occurs when the heart stops beating, abruptly and without warning. If this happens, blood stops flowing to the brain and other vital organs. If the heartbeat is not restored with an electrical shock immediately, SCD follows within minutes. According to the Heart Rhythm Society, approximately 325,000 incidences of SCD happen in adults each year, and it is one of the leading causes of death in the U.S. SCA claims one life every 90 seconds, taking more lives each year than breast cancer, lung cancer or AIDS.  

The study evaluated 112,700 women in the Nurses' Health Study, an ongoing study that began in 1976. Daily exposures to PM less than 2.5 microns in diameter (PM2.5) and mean temperatures were determined at the home address of each participant. For each SCD case, the exposure to PM on the day of SCD was compared to that on control days matched on the day of the week and selected from the same month as the case day. 

There were 221 SCDs identified between 1999-2011. Findings indicated increased exposures to PM were associated with a suggestive linear increase in SCD risk. The association was significantly modified by ambient temperature. SCD was associated with PM in the lowest quartiles of temperature (below 39.03 F°), but no associations were observed at higher temperatures (ranging from 54.66-68.91°F). Of note, all PM2.5 exposures in this study were far below the current daily U.S. Environmental Protection Agency (EPA) standard for PM2.5 (35 µg/m3). 

"Before this study, the relationship between short-term exposure to air pollution and sudden cardiac death was not known, especially within the lower-risk, general population. Our study demonstrates that even a small amount of air pollution on colder days could put people at risk," explained lead author Jaime Hart, SCD, assistant professor at Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School. "To reduce exposures, people who don't live with smokers should try to keep their windows closed and minimize outdoor activities on cold days and to be aware of pollution levels in the air. We hope our results will raise awareness of air pollution as a risk factor and potentially lead to a review of EPA standards, to ultimately, help reduce the number of sudden cardiac death cases." 

The authors note that future studies are warranted to further understand the cause of this linear relationship of air pollution and SCD and to see if it is observed in other populations, including men. 

Read about Hart's related research on air pollution and cardiovascular disease and how the combination increased risk for women with diabetes.

Heart Rhythm 2018 is the most comprehensive educational program for heart rhythm professionals, featuring more than 200 educational sessions and more than 140 exhibitors showcasing innovative products and services. For more information: www.hrssessions.org

Find links to all the Heart Rhythm 2018 Late-breaking Studies

 

#HRS2018 #HRS18

Related Content

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 

News | Cardiac Diagnostics | July 29, 2021
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation Ambula
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device

News | Cardiac Diagnostics | July 01, 2021
July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc.
Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Detecting heart disease with OCT imaging of the eye.Getty Images

Ophthalmic optical coherence tomography (OCT) scan view of the macula in retina with vessels. Getty Images
 

News | Cardiac Diagnostics | March 08, 2021
March 8, 2021 — In a new study from Shiley Eye Institute at UC San Diego Health, researchers have identified a potent
Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia.

Alivecor's pocket ECG system allows consumers or cardiologists to record a single lead ECG strip on a smartphone. AI algorithms can determine if their ECG is normal or abnormal and identify the arrhythmia. 

News | Cardiac Diagnostics | March 03, 2021
March 3, 2021 — AliveCor recently announced a new collaboration with AstraZeneca to research new disease management s
A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images Health disparities in cardiovascular disease.

A study of more than 100 million Americans in 3,123 counties found a correlation between cardiac death and their level of income. Getty Images

News | Cardiac Diagnostics | February 02, 2021
February 2, 2021 — A new study has found in the U.S.
A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

A new study highlights the importance of continued public education regarding the risks of cigarette smoking and the failure of dual use with vaping to reduce cardiovascular risk. Getty Images

News | Cardiac Diagnostics | January 06, 2021
January 6, 2021 — Smoking traditional cigarettes in addition to using e-cigarettes results in harmful health effects
The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia.

The Mesuron Inc. Avalon-H90 uses magnetometers to detect myocarditis in patients without any physical contact. It uses ventricular repolarization dynamics analysis software to look for abnormalities. The vendor said it is more specific than using ECG. It detects the multidimensional dynamics of the electrical activity caused by differences in functions of electrical action potential of normal heart tissues and abnormal ones with hypoxia. 

News | Cardiac Diagnostics | October 06, 2020
October 6, 2020 — A new technology being developed by U.S.-based Mesuron Inc.
With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry  #Amyloidosis

With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. This is Figure 2, showing how SPECT imaging allows the reader to distinguish between blood pool activity (ventricular cavity, etc) and myocardial activity and identify regional myocardial differences in radiotracer uptake.

News | Cardiac Diagnostics | March 05, 2020
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the en